aap Implantate AG: Capital Increase of approx. 10%

(PresseBox) ( Berlin, )
The Management Board of aap Implantate AG, a medical technology company listed on the Frankfurt stock exchange in the Prime Standard segment, decided today with the Supervisory Board's approval to increase its capital stock from authorized capital by EUR 2,788,186. This corresponds to approx. 10% of the present capital stock. The 2,788,186 new shares are subscribed, excluding rights entitlement for existing shareholders, by way of a private placement in return for a cash contribution at a price of EUR 1.09 per no-par share. The company's capital stock thereby increases by EUR 2,788,186 from the present EUR 27,881,870 to EUR 30,670,056.

The inflow of funds of approx. EUR 3 million from the capital increase is to serve the purpose of funding further growth by launching new products and entering new markets in Europe and the United States of America as well as strengthening the financial basis of aap.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.